We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals
ATNM

37 hedge funds and large institutions have $13.7M invested in Actinium Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 3

308% more call options, than puts

Call options by funds: $2.81M | Put options by funds: $689K

37% more capital invested

Capital invested by funds: $9.99M → $13.7M (+$3.68M)

1.09% less ownership

Funds ownership: 9.65% → 8.56% (-1.1%)

8% less funds holding

Funds holding: 40 → 37 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
37
Holders Change
-3
Holders Change %
-7.5%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
15
Reduced
3
Closed
7
Calls
$2.81M
Puts
$689K
Net Calls
+$2.12M
Net Calls Change
-$14.2M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.94M
2
State Street
State Street
Massachusetts
+$434K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$415K
4
PA
Pinnacle Associates
New York
+$269K
5
BlackRock
BlackRock
New York
+$178K

Top Sellers

Rank Fund Capital Flow
1
SCM
Silverarc Capital Management
Massachusetts
-$350K
2
ICP
Interchange Capital Partners
Pennsylvania
-$102K
3
Marshall Wace
Marshall Wace
United Kingdom
-$99K
4
DLG
Daniel L. Goodwin
-$78.5K
5
Group One Trading
Group One Trading
Illinois
-$34.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
GAM
26
Gemmer Asset Management
California
$3K – – –
TFO
27
Tarbox Family Office
California
$3K +$2.6K +332 New
GFPC
28
Global Financial Private Client
Florida
$2.06K – – –
GI
29
Gradient Investments
Minnesota
$1K – – –
Northwestern Mutual Wealth Management
30
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
RG
31
Retirement Group
California
$1K – – –
TWA
32
TCI Wealth Advisors
Arizona
$1K – – –
GEA
33
Glen Eagle Advisors
New Jersey
$47 – – –
SCM
34
Silverarc Capital Management
Massachusetts
– -$350K -45,910 Closed
Marshall Wace
35
Marshall Wace
United Kingdom
– -$99K -13,019 Closed
Group One Trading
36
Group One Trading
Illinois
– -$34.4K -4,385 Closed
SWM
37
Spire Wealth Management
Virginia
– -$15K -1,800 Closed
SFS
38
Sowell Financial Services
Arkansas
– -$5K -636 Closed
IA
39
IFP Advisors
Florida
– -$1.04K -133 Closed
Bank of America
40
Bank of America
North Carolina
– -$377 -48 -54%
1
2

ATNM Hedge Fund Activity: Q2 2021 in Review

37 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q2 2021, worth a combined $13.7M — up 37% from $9.99M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ATNM and 4 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 15 added.

The largest buyer was Vanguard Group, adding an estimated $1.94M. The largest seller was Silverarc Capital Management, exiting entirely with an estimated $350K sold.

  • 37 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q2 2021, down from 40 in Q1 2021.
  • Funds reported $13.7M of Actinium Pharmaceuticals stock for Q2 2021, up 37% quarter-over-quarter.
  • 4 funds opened new Actinium Pharmaceuticals positions in Q2 2021 and 7 closed out, a net change of -3 holders.
  • The largest Actinium Pharmaceuticals buyer in Q2 2021 was Vanguard Group, an estimated $1.94M added.
  • The largest Actinium Pharmaceuticals seller in Q2 2021 was Silverarc Capital Management, an estimated $350K sold.

Based on aggregated 13F filings for Q2 2021.